Search results
Results from the WOW.Com Content Network
miraDry is a microwave-based medical device developed by Miramar Labs which is used in the treatment of axillary hyperhidrosis. [1] It was approved by the United States Food and Drug Administration (FDA) in 2011 and was also approved in Europe. [1] miraDry selectively destroys axillary sweat glands without affecting the superficial layers of ...
Glycopyrronium tosylate, sold under the brand name Qbrexza among others, is a medication used for the treatment of primary axillary hyperhidrosis. [ 1 ] [ 2 ] [ 3 ] It was approved for medical use in the United States in June 2018, [ 4 ] and in Japan in January 2022.
Focal hyperhidrosis, also known as primary hyperhidrosis, is a disease characterized by an excessive sweating localized in certain body regions (particularly palms, feet and underarms). Studies suggest that this condition, affecting between 1% and 3% of the US population, seems to have a genetic predisposition in about two thirds of those affected.
Hyperhidrosis is a medical condition in which a person exhibits excessive sweating, [1] [2] more than is required for the regulation of body temperature. [3] Although it is primarily a physical burden, hyperhidrosis can deteriorate the quality of life of the people who are affected from a psychological, emotional, and social perspective. [4]
Hyperhidrosis is the medical term for excessive sweating, per Johns Hopkins Medicine. While Graziadei hasn’t commented on the procedure, in the video, he seems to be taking the injections in stride.
Endoscopic thoracic sympathectomy (ETS) is a surgical procedure in which a portion of the sympathetic nerve trunk in the thoracic region is destroyed. [1] [2] ETS is used to treat excessive sweating in certain parts of the body (focal hyperhidrosis), facial flushing, Raynaud's disease and reflex sympathetic dystrophy.
Palmoplantar hyperhidrosis is excessive sweating localized to the palms of the hands and soles of the feet. It is a form of focal hyperhidrosis in that the excessive sweating is limited to a specific region of the body. As with other types of focal hyperhidrosis (e.g. axillary and craniofacial) the sweating tends to worsen during warm weather. [1]
This technique is implicitly non-invasive. Damage to the superficial dermis is prevented through cooling of the external surface of the miraDry unit, localising the heating and cell destruction to the lower, gland-containing strata. Because sweat glands do not regenerate after treatment, the results are lasting.